These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18329310)

  • 1. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals.
    Karelis AD; Rabasa-Lhoret R
    Diabetes Metab; 2008 Apr; 34(2):183-4. PubMed ID: 18329310
    [No Abstract]   [Full Text] [Related]  

  • 2. Ischemia-modified albumin as an oxidative stress biomarker in obesity.
    Piva SJ; Duarte MM; Da Cruz IB; Coelho AC; Moreira AP; Tonello R; Garcia SC; Moresco RN
    Clin Biochem; 2011 Mar; 44(4):345-7. PubMed ID: 21159315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current issues in the identification and treatment of metabolically healthy but obese individuals.
    Plourde G; Karelis AD
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):455-9. PubMed ID: 24529490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids and neopterin in urine as new biomarkers of malnutrition and inflammation in the elderly.
    Hrnciarikova D; Hyspler R; Vyroubal P; Klemera P; Hronek M; Zadak Z
    Nutrition; 2009 Mar; 25(3):303-8. PubMed ID: 19019628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a new marker for cardiac risk.
    Harv Mens Health Watch; 2002 Jan; 6(6):4-7. PubMed ID: 11823169
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population.
    Bozorgmanesh MR; Hadaegh F; Padyab M; Mehrabi Y; Azizi F
    Ann Nutr Metab; 2008; 53(1):13-22. PubMed ID: 18772585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL-cholesterol level provides additional prognosis in acute coronary syndromes.
    Correia LC; Rocha MS; Esteves JP
    Int J Cardiol; 2009 Aug; 136(3):307-14. PubMed ID: 18706714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilirubin concentration and cardiovascular risk profile.
    Lippi G; Targher G; Montagnana M; Salvagno GL; Guidi GC
    Liver Int; 2009 Feb; 29(2):315-6. PubMed ID: 18662265
    [No Abstract]   [Full Text] [Related]  

  • 10. C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis.
    Rosenau BJ; Costenbader KH; Schur PH
    Vasc Med; 2008 Feb; 13(1):25-8. PubMed ID: 18372435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically healthy but obese individuals: relationship with hepatic enzymes.
    Messier V; Karelis AD; Robillard ME; Bellefeuille P; Brochu M; Lavoie JM; Rabasa-Lhoret R
    Metabolism; 2010 Jan; 59(1):20-4. PubMed ID: 19709695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin in patients with elevated C-reactive protein.
    Jenny-Avital ER
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
    [No Abstract]   [Full Text] [Related]  

  • 13. NASH and cardiovascular biomarkers.
    Ercin CN; Dogru T; Tasci I; Erdem G; Sonmez A; Tapan S
    Obesity (Silver Spring); 2009 Apr; 17(4):627; author reply 627. PubMed ID: 19322144
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
    Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
    Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can statins help healthy people?
    Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):1. PubMed ID: 19370796
    [No Abstract]   [Full Text] [Related]  

  • 16. Seasonal variation in serum cholesterol levels may be another explanation for seasonal variation in acute myocardial infarction.
    Cheng TO
    Int J Cardiol; 2005 Sep; 104(1):101. PubMed ID: 16137517
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosuvastatin in patients with elevated C-reactive protein.
    Chan PS; Nallamothu BK; Hayward RA
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of pravastatin on blood lipids and serum high sensitive C-reactive protein in patients undergoing conventional coronary artery bypass grafting under on-pump: a clinical study of 81 cases].
    Wang XS; Mei YQ; Lu YF; Cai JZ; Ji Q; Tang CZ; Li TC; Hu DY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):101-4. PubMed ID: 18353213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk.
    Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Aparna A; Pavithran P
    Clin Exp Hypertens; 2008 Jul; 30(5):367-74. PubMed ID: 18633759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.